DNA aptamers selection for carcinoembryonic antigen (CEA)

被引：15

作者：

Abreu de Melo, Mariane Izabella ^{[1
]}

Correa, Cristiane Rodrigues ^{[1
]}

Cunha, Pricila da Silva ^{[1
]}

de Goes, Alfredo Miranda ^{[2
]}

Gomes, Dawidson Assis ^{[2
]}

Ribeiro de Andrade, Antero Silva ^{[1
]}

机构：

[1] Comissao Nacl Energia Nucl, Ctr Desenvolvimento Tecnol Nucl, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil

[2] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2020年 / 30卷 / 15期

关键词：

COLON-CANCER CELLS; BREAST-CANCER; RNA APTAMER; LABEL-FREE; APTASENSOR; MOLECULES; DNAZYME;

D O I：

10.1016/j.bmcl.2020.127278

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Carcinoembryonic antigen (CEA) is a glycoprotein antigen generally used for diagnosis, prognosis and treatment monitoring of several types of tumors, including colorectal cancer. Nucleic acid aptamers are DNA or RNA oligonucleotides capable of binding with high specificity and affinity to a molecular target. The aim of this study was to obtain aptamers specific to CEA for use as radiopharmaceuticals in colorectal cancer diagnosis. Five aptamers were selected through the Systematic Evolution of Ligands by EXponencial Enrichment (SELEX) and tested using T84 (CEA+) and Hela (CEA−) cells. Apta 3 and Apta 5 showed the best results presenting high specificity and affinity for T84 cells, with dissociation constants (Kd) of 60.4 ± 5.7 nM and 37.8 ± 5.8 nM, respectively. These results indicate that Apta 3 and Apta 5 are promising candidates for identifying tumor cells that overexpress CEA. © 2020 Elsevier Ltd

引用

页数：6

共 50 条

[41] COLORECTAL-CARCINOMA AND CARCINOEMBRYONIC ANTIGEN (CEA)
LADENSON, JH
MCDONALD, JM
LANDT, M
SCHWARTZ, MK
CLINICAL CHEMISTRY, 1980, 26 (08) : 1213 - 1220
[42] IMMUNOCHEMICAL STUDIES OF CARCINOEMBRYONIC ANTIGEN (CEA) VARIANTS
ICHIKI, AT
WENZEL, KL
QUIRIN, YP
LANGE, RD
EVELEIGH, J
BRITISH JOURNAL OF CANCER, 1976, 33 (03) : 273 - 278
[43] ASSOCIATION OF CARCINOEMBRYONIC ANTIGEN (CEA) ACTIVITY WITH HEPARIN
WU, JT
WU, LH
HERBST, JJ
FEDERATION PROCEEDINGS, 1977, 36 (03) : 643 - 643
[44] SEARCH FOR CARCINOEMBRYONIC ANTIGEN (CEA) IN ADENOMAS OF COLON
CRICHLOW, RW
WHITE, RR
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1970, 11 : 18 - &
[45] IMMUNOCHEMICAL ANALYSIS OF FRAGMENTS OF CARCINOEMBRYONIC ANTIGEN (CEA)
KRANTZ, M
LAFERTE, S
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 297 - 297
[46] REAGENTS FOR RADIOIMMUNOLOGICAL DETERMINATION OF CARCINOEMBRYONIC ANTIGEN (CEA)
ALBERT, Z
BALBIERZ, H
BREBOROWICZ, J
HARLOZINSKA, A
LISOWSKA, E
LUCKA, B
MAJEWSKI, P
RICHTER, R
RUSSIN, K
SIUDA, A
ZAWADZKA, H
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 1978, 26 (1-6) : 227 - 229
[47] BINDING OF WHEAT HEMAGGLUTININ TO CARCINOEMBRYONIC ANTIGEN (CEA)
SINGH, K
MACH, JP
EXPERIENTIA, 1976, 32 (06): : 774 - 775
[48] IMMUNOLOGICAL HETEROGENEITY OF SERUM CARCINOEMBRYONIC ANTIGEN (CEA)
VRBA, R
ALPERT, E
ISSELBACHER, KJ
IMMUNOCHEMISTRY, 1976, 13 (01): : 87 - 89
[49] CLINICAL EVALUATION OF ASSAY FOR CARCINOEMBRYONIC ANTIGEN (CEA)
PAPACHRISTOU, D
TERZ, JJ
LAWRENCE, W
VIRGINIA MEDICAL, 1974, 101 (02): : 108 - +
[50] CELLULAR-IMMUNITY AND CARCINOEMBRYONIC ANTIGEN (CEA)
HEIDEL, G
GROSSMAN, H
MUELLER, M
IRMSCHER, J
KOTZSCH, M
ONCODEVELOPMENTAL BIOLOGY AND MEDICINE, 1981, 2 (03): : 208 - 208

← 1 2 3 4 5 →